Skip to Main Content

Author Details

Colm Atkins
Rutgers University
2007
19
11
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36869692Nipah Virus Bangladesh Infection Elicits Organ-Specific Innate and Inflammatory Responses in the Marmoset Model.J Infect Dis2023
38011306RIPK3 promotes brain region-specific interferon signaling and restriction of tick-borne flavivirus infection.PLoS Pathog2023
37546744Neuronal DAMPs exacerbate neurodegeneration via astrocytic RIPK3 signaling.bioRxiv2023
36747672RIPK3 promotes brain region-specific interferon signaling and restriction of tick-borne flavivirus infection.bioRxiv2023
35533195Ubiquitination of Ebola virus VP35 at lysine 309 regulates viral transcription and assembly.PLoS Pathog2022
34333522Fibrillar α-synuclein induces neurotoxic astrocyte activation via RIP kinase signaling and NF-κB.Cell Death Dis2021
35056541Tilorone-Dihydrochloride Protects against Rift Valley Fever Virus Infection and Disease in the Mouse Model.Microorganisms2021
34297942Developing human pluripotent stem cell-based cerebral organoids with a controllable microglia ratio for modeling brain development and pathology.Stem Cell Reports2021
31694946VAMP8 Contributes to the TRIM6-Mediated Type I Interferon Antiviral Response during West Nile Virus Infection.J Virol2020
30442185Human neural stem cell-derived neuron/astrocyte co-cultures respond to La Crosse virus infection with proinflammatory cytokines and chemokines.J Neuroinflammation2018
30192975Natural History and Pathogenesis of Wild-Type Marburg Virus Infection in STAT2 Knockout Hamsters.J Infect Dis2018
29912426Experimental Infection of Syrian Hamsters With Aerosolized Nipah Virus.J Infect Dis2018
28679761The Host E3-Ubiquitin Ligase TRIM6 Ubiquitinates the Ebola Virus VP35 Protein and Promotes Virus Replication.J Virol2017
29181086Recent advances in the development of antiviral therapeutics for Rift Valley fever virus infection.Future Virol2017
28539439Contribution of Human Lung Parenchyma and Leukocyte Influx to Oxidative Stress and Immune System-Mediated Pathology following Nipah Virus Infection.J Virol2017
26116756Benzimidazole analogs inhibit respiratory syncytial virus G protein function.Antiviral Res2015
24464431Global Human-Kinase Screening Identifies Therapeutic Host Targets against Influenza.J Biomol Screen2014
22435452Screening methods for influenza antiviral drug discovery.Expert Opin Drug Discov2012
17878931Immunological change in a parasite-impoverished environment: divergent signals from four island taxa.PLoS One2007
  • 1 - 19 of 19

Recommended Authors

James Logue
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 2017
Number of shared co-authors 4
Veronica V Rezelj
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Career Start Year 2015
Number of shared co-authors 4
Stuart Weston
University of Maryland School of Medicine
Career Start Year 2014
Number of shared co-authors 4
David Sachs
Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 3
Shashank Tripathi
Indian Institute of Science
Career Start Year 2011
Number of shared co-authors 5
Jennifer Tisoncik-Go
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2009
Number of shared co-authors 0
Carles Mart??nez-Romero
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 4
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 0
Nicholas S Heaton
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 3
Amie J Eisfeld
Influenza Research Institute, University of Wisconsin-Madison
Career Start Year 2006
Number of shared co-authors 0
Jessica L Smith
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 2005
Number of shared co-authors 0
Emmie de Wit
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2004
Number of shared co-authors 4
Shirit Einav
Stanford University School of Medicine
Career Start Year 2002
Number of shared co-authors 1
Balaji Manicassamy
University of Iowa
Career Start Year 2002
Number of shared co-authors 5
Luis Martinez-Sobrido
Texas Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 5
Megan L Shaw
Icahn School of Medicine at Mount Sinai
Career Start Year 2000
Number of shared co-authors 4
Victor R DeFilippis
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 2000
Number of shared co-authors 0
Gaya K Amarasinghe
Washington University School of Medicine at St. Louis
Career Start Year 2000
Number of shared co-authors 4
Daisy W Leung
Washington University School of Medicine
Career Start Year 1999
Number of shared co-authors 3
Sonja M Best
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 10
Pei-Yong Shi
University of Texas Medical Branch
Career Start Year 1996
Number of shared co-authors 10
Abraham L Brass
University of Massachusetts Medical School
Career Start Year 1995
Number of shared co-authors 2
Ana Fernandez-Sesma
Icahn School of Medicine at Mount Sinai
Career Start Year 1993
Number of shared co-authors 7
Matthew B Frieman
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 1993
Number of shared co-authors 5
Sara Cherry
University of Pennsylvania
Career Start Year 1993
Number of shared co-authors 3
Alec J Hirsch
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Career Start Year 1992
Number of shared co-authors 0
Mark T Heise
University of North Carolina at Chapel Hill.
Career Start Year 1990
Number of shared co-authors 2
Adolfo Garc??a-Sastre
Icahn School of Medicine at Mount Sinai
Career Start Year 1989
Number of shared co-authors 14
Michael Gale
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 1988
Number of shared co-authors 2
Michael S Diamond
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 2

Collaborators

Alexander N Freiberg
University of Texas Medical Branch
Co-authored papers 10
Preeti Bharaj
University of Texas Medical Branch
Co-authored papers 3
Ricardo Rajsbaum
University of Texas Medical Branch
Co-authored papers 3
Benhur Lee
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Brian E Dawes
University of Texas Medical Branch, 301 University Boulevard
Co-authored papers 2
Adam Hage
University of Texas Medical Branch
Co-authored papers 2
Maria I Giraldo
University of Texas Medical Branch
Co-authored papers 2
Sarah van Tol
University of Texas Medical Branch
Co-authored papers 2
Leopoldo Aguilera-Aguirre
University of Texas Medical Branch
Co-authored papers 1
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 1
Jeffrey R Johnson
Gladstone Institutes
Co-authored papers 1
Priya Luthra
Trudeau Institute
Co-authored papers 1
Christopher F Basler
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Benjamin R tenOever
NYU Grossman School of Medicine
Co-authored papers 1
Lisa Miorin
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Krister Wennerberg
University of Copenhagen
Co-authored papers 1
Release 1.2